Stearyltrimethylammonium (STMA) is a quaternary ammonium cationic surfactant. It is commonly used in hair care products, cosmetics, and detergents. STMA is synthesized through the reaction of stearyl alcohol with trimethylamine. Its cationic nature allows it to interact with negatively charged surfaces, leading to its surfactant properties. It's often used in shampoos and conditioners for its ability to reduce static cling and impart softness to hair. The importance of STMA lies in its versatility and effectiveness in various applications. Researchers study STMA to understand its impact on human health and the environment, as well as to explore its potential applications in other fields, such as biomedicine and drug delivery.'
stearyltrimethylammonium: cationic detergent; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 8156 |
| CHEMBL ID | 109458 |
| CHEMBL ID | 1179998 |
| SCHEMBL ID | 48999 |
| MeSH ID | M0060868 |
| Synonym |
|---|
| bdbm50147563 |
| trimethyl-octadecyl-ammonium; bromide |
| stearyltrimethylammonium |
| CHEMBL109458 , |
| 15461-40-2 |
| NCGC00248615-01 |
| stma-c |
| dj0m4hzy00 , |
| 1-octadecanaminium, n,n,n-trimethyl- |
| unii-dj0m4hzy00 |
| CHEMBL1179998 |
| SCHEMBL48999 |
| n,n,n-trimethyloctadecan-1-aminium |
| DTXSID8048078 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||